 |
Third Harmonic Bio
Last updated: May 05, 2024
CEO Natalie Holles
Country: USA | Funding: $155M (+)
Website: https://www.thirdharmonicbio.com/
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
Website: https://www.thirdharmonicbio.com/
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.